Gilead Sciences (GILD) Q4 Revenue Tops Views, Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Bullish Options Positioning in Gilead Sciences (GILD) Targets Upside in Shares Over the Coming Months -Susquehanna
February 7, 2018 2:49 PM ESTSusquehanna options strategist Alison Edwards notes bullish options positioning in Gilead Sciences (NASDAQ: GILD), as an opening investor bought 10,000 Mar 85 Calls for $2.20
... More